Endocyte (ECYT) Tops Q4 EPS by 4c
Tweet
Share
E-mailGet Alerts ECYT Hot Sheet
Join SI Premium – FREE
Endocyte (NASDAQ: ECYT) reported Q4 EPS of ($0.23), $0.04 better than the analyst estimate of ($0.27).
For earnings history and earnings-related data on Endocyte (ECYT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla to launch Cybercab in Austin this month - report
- uCloudlink Group Inc. (UCL) Misses Q2 EPS by 1c ; Offers Guidance
- Carvana's share gains and production growth remain on track, Wells Fargo says
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
